For those working with 5mg vials, the 5mg/2ml dosage chart provides the specific measurements needed
Fielding et al
Its difficult to determine an A1C threshold at which you might change your mind about whether to use a GLP-1 receptor agonist to manage cardiovascular risk. 1 Post hoc results revealed consistent cardiovascular benefits across all BMI baseline categories, with more pronounced benefits in participants who had higher A1C levels at baseline
They provide noticeable, though temporary, hydration & de-puffing, with a comfortable, secure fit
Future randomized trials should evaluate iron indices, hepcidin levels, ferritin, transferrin saturation, and hemoglobin trends in patients treated with GLP-1 receptor agonists
If your B12 levels are already adequate, injecting more does not produce documented improvements in energy or cognition in clinical studies